SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001600132-19-000166
Filing Date
2019-12-17
Accepted
2019-12-17 08:24:55
Documents
20
Period of Report
2019-12-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-kdecember2019ilddata.htm 8-K 47637
2 EXHIBIT 10.1 bellerophoncreditfacilit.htm EX-10.1 11844
3 EXHIBIT 99.1 pressreleasedecember172019.htm EX-99.1 21991
4 EXHIBIT 99.2 bellerophoncohort2callde.htm EX-99.2 12755
5 bellerophoncohort2callde001.jpg GRAPHIC 124235
6 bellerophoncohort2callde002.jpg GRAPHIC 147211
7 bellerophoncohort2callde003.jpg GRAPHIC 55545
8 bellerophoncohort2callde004.jpg GRAPHIC 65732
9 bellerophoncohort2callde005.jpg GRAPHIC 60245
10 bellerophoncohort2callde006.jpg GRAPHIC 86806
11 bellerophoncohort2callde007.jpg GRAPHIC 57858
12 bellerophoncohort2callde008.jpg GRAPHIC 64036
13 bellerophoncohort2callde009.jpg GRAPHIC 51348
14 bellerophoncohort2callde010.jpg GRAPHIC 127547
15 bellerophoncreditfacilit001.jpg GRAPHIC 153279
16 bellerophoncreditfacilit002.jpg GRAPHIC 244902
17 bellerophoncreditfacilit003.jpg GRAPHIC 37376
18 bellerophoncreditfacilit004.jpg GRAPHIC 51400
19 bellerophoncreditfacilit005.jpg GRAPHIC 33463
20 blphpica04.jpg GRAPHIC 14227
  Complete submission text file 0001600132-19-000166.txt   1991333
Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Filer) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36845 | Film No.: 191288626
SIC: 2834 Pharmaceutical Preparations